Tempus AI
AI-powered precision medicine
About Tempus AI
Tempus AI is a technology company advancing precision medicine by combining AI with one of the world's largest libraries of clinical and molecular data. The company has built a dataset of over 7 million de-identified patient records with matched genomic, transcriptomic, and clinical outcome data, enabling AI models that help physicians make more informed treatment decisions.
Tempus offers genomic profiling tests that sequence patients' tumors and use AI to identify relevant biomarkers, match patients to clinical trials, and suggest targeted therapies. The company's AI platform serves oncologists, researchers, and pharmaceutical companies, providing insights that accelerate drug development and improve patient outcomes.
The company went public in 2024 and has expanded beyond oncology into cardiology, radiology, and mental health. Tempus' data and AI platform is used by a majority of academic medical centers in the US and by leading pharmaceutical companies for drug development and clinical trial optimization.
Products & Services
Tempus xT
Comprehensive genomic profiling with AI-driven therapy matching for oncology
Tempus Lens
AI analytics platform for clinical and genomic data exploration
Tempus ONE
AI assistant for physicians providing real-time clinical decision support
Leadership
Notable Achievements
- ✓ IPO in 2024 as leading AI precision medicine company
- ✓ 7M+ de-identified patient records in dataset
- ✓ Used by majority of US academic medical centers
- ✓ Expanded from oncology into cardiology and radiology
Competitive Landscape
Companies competing in the same space as Tempus AI.
NexChron Coverage
Latest articles mentioning Tempus AI
Tempus AI Acquires Personalis for $1.5 Billion to Expand Into Cancer Recurrence Monitoring
Tempus AI's $1.5 billion acquisition of Personalis combines AI-powered cancer diagnosis with molecular residual disease testing to create an integrated surveillance platform for post-treatment recurrence monitoring.
UK Opens Public Consultation on AI Workplace Monitoring — Responses Due September 30
The UK government is seeking input on whether employers should need explicit consent before deploying AI surveillance, biometric tracking, and algorithmic performance management at work.
California's Frontier AI Safety Bill Lands on Newsom's Desk — September 30 Deadline
California's Safe and Secure Innovation for Frontier AI Models Act passed both chambers and awaits Governor Newsom's signature by September 30, which would make California the first US state to mandate pre-deployment safety testing for large AI models.
Colorado's Revised AI Rules Due September 23 as California Bills Advance; U.S. Governance Patchwork Deepens
Colorado releases revised ADMT draft rules September 23, while California AI bills advance and the FTC issues a new algorithmic targeting order—creating the most concentrated state-level AI compliance pressure of the year.
Siemens and NVIDIA Are Building an Industrial AI Operating System — Starting With One Factory in Germany
Siemens and NVIDIA are expanding their partnership to build an Industrial AI Operating System — and a factory in Erlangen, Germany will be the first site to run entirely on it.
Pentagon Tests OpenAI and Google Models to Replace Claude in Classified Systems
The Pentagon is actively testing OpenAI and Google AI models as potential replacements for Anthropic's Claude in classified defense systems, confirming that the most secure AI contract market is now openly competitive.
ASUS Launches AI Healthcare Ecosystem at Computex 2026: Portable Ultrasound, Smart Watch, No-Code Clinical AI
ASUS launched a connected AI healthcare ecosystem at Computex 2026, pairing the DuoScan handheld ultrasound and VivoWatch 6 Plus wearable with a no-code clinical AI platform that lets clinicians build agentic workflows without programming.
92% of Security Professionals Now Worried About AI Agent Over-Permissions Across Enterprise Systems
The Cloud Security Alliance's 2026 survey finds 92 percent of security professionals concerned about AI agents holding excessive permissions across enterprise systems — with only 37 percent of organizations having formal governance policies in place.
Microsoft's MDASH Agentic Security System Sets New Benchmark for AI-Powered Cyber Defense
Microsoft launched MDASH, a multi-model agentic security system that coordinates AI agents to detect and respond to threats at machine speed — and claims top scores on industry cybersecurity benchmarks.
OpenAI Files Confidential IPO Prospectus With SEC, Eyes September 2026 Listing
OpenAI filed a confidential IPO prospectus with the SEC on May 22, targeting a September public listing that would be the largest AI-sector debut in market history.
Financial Disclosure: NexChron provides financial data for informational purposes only. This is not investment advice, a recommendation to buy or sell securities, or an offer to transact. Stock prices are delayed up to 15 minutes and sourced from Yahoo Finance. Funding round data is compiled from public reports and may not reflect the most current information. Company valuations, revenue estimates, and financial projections are based on publicly available data and may be inaccurate or outdated. Always consult a qualified financial advisor before making investment decisions. NexChron, its founder, and contributors may hold positions in companies mentioned on this site.